The Cooper Companies, Inc. (NASDAQ:COO – Get Free Report) has earned a consensus rating of “Moderate Buy” from the sixteen brokerages that are covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, six have given a hold recommendation, eight have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $90.3077.
COO has been the topic of several analyst reports. Citigroup reaffirmed a “neutral” rating and set a $88.00 price target (up from $72.00) on shares of Cooper Companies in a research report on Monday, December 8th. Morgan Stanley raised their target price on Cooper Companies from $76.00 to $83.00 and gave the stock an “equal weight” rating in a report on Monday, December 8th. JPMorgan Chase & Co. boosted their price target on Cooper Companies from $66.00 to $78.00 and gave the company a “neutral” rating in a report on Friday, December 5th. Piper Sandler reaffirmed an “overweight” rating and set a $94.00 price objective (up previously from $83.00) on shares of Cooper Companies in a research note on Friday, December 5th. Finally, Weiss Ratings upgraded shares of Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, January 12th.
Get Our Latest Analysis on COO
Cooper Companies Stock Performance
Cooper Companies (NASDAQ:COO – Get Free Report) last released its quarterly earnings data on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. Cooper Companies had a net margin of 9.16% and a return on equity of 10.02%. The firm had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.06 billion. During the same quarter in the prior year, the business earned $1.04 earnings per share. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. On average, analysts anticipate that Cooper Companies will post 3.98 EPS for the current year.
Insider Buying and Selling
In related news, Director Lawrence Erik Kurzius acquired 2,000 shares of Cooper Companies stock in a transaction on Wednesday, December 17th. The stock was bought at an average cost of $82.50 per share, for a total transaction of $165,000.00. Following the completion of the transaction, the director owned 7,777 shares of the company’s stock, valued at approximately $641,602.50. The trade was a 34.62% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Maria Rivas bought 1,000 shares of the business’s stock in a transaction dated Thursday, December 18th. The shares were bought at an average cost of $82.13 per share, with a total value of $82,130.00. Following the purchase, the director directly owned 11,141 shares of the company’s stock, valued at approximately $915,010.33. This represents a 9.86% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have bought 16,014 shares of company stock worth $1,304,416 in the last 90 days. 1.98% of the stock is owned by insiders.
Hedge Funds Weigh In On Cooper Companies
Hedge funds and other institutional investors have recently made changes to their positions in the company. Bell Investment Advisors Inc lifted its holdings in Cooper Companies by 106.3% in the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock valued at $29,000 after purchasing an additional 219 shares in the last quarter. True Wealth Design LLC grew its holdings in shares of Cooper Companies by 484.8% during the fourth quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after buying an additional 383 shares in the last quarter. Board of the Pension Protection Fund acquired a new stake in shares of Cooper Companies in the fourth quarter valued at about $41,000. J.Safra Asset Management Corp lifted its stake in shares of Cooper Companies by 204.8% in the second quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company’s stock worth $36,000 after buying an additional 340 shares in the last quarter. Finally, CYBER HORNET ETFs LLC acquired a new position in Cooper Companies during the second quarter worth about $36,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.
Cooper Companies Company Profile
Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.
The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.
Featured Articles
- Five stocks we like better than Cooper Companies
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.
